GLP-1 drugs have turned Eli Lilly into a trillion-dollar company. But growing competition and changing consumer habits are creating new investment opportunities. Here's where Frank is looking next.

The post Eli Lilly won the first round of the weight-loss boom. Who wins next? appeared first on Curzio Research.